Maple Grove, United States
Metavention, Inc., founded in 2012 and headquartered in Minneapolis, Minnesota, is a pioneering medical device company focusing on Biotechnology and Health Care. Their mission, encapsulated in the slogan, "Together, we can effect real change in the treatment of metabolic disease," underscores their commitment to innovating treatments for metabolic diseases.
In an era where chronic illnesses like diabetes are on the rise, Metavention stands out by developing novel solutions that could potentially transform standard care practices. Their innovative approach attracted a significant $65.00M Series C investment on 08 January 2018, backed by prominent investors such as New Enterprise Associates, Versant Ventures, Sanderling Ventures, Horowitz Group, and RK Mellon. This solid financial backing reflects investor confidence in their technology and business model, positioning Metavention as a promising player in the industry.
